Deal-hungry Ipsen is at it again, pledging just over $1 billion for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere Zaiming, that is due to start clinical testing ...
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS) ...
THOSE who heard Prof. Southwell's lecture to the London Mathematical Society in 1937 will well remember how he communicated to his audience some of the great enthusiasm with which he had reacted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results